1-2 of 2
Nicholas J. Boddicker
Close
Sort by
Journal Articles

Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis

Clinical Trials & Observations
Geffen Kleinstern, Nicholas J. Boddicker, Daniel R. O’Brien, Cristine Allmer, Kari G. Rabe, Aaron D. Norman, Rosalie Griffin, Huihuang Yan, Tao Ma, Timothy G. Call, Laura Bruins, Sochilt Brown, Cecilia Bonolo de Campos, Curtis A. Hanson, Jose F. Leis, Wei Ding, Celine M. Vachon, Neil E. Kay, Christopher C. Oakes, Alexander S. Parker, Danielle M. Brander, J. Brice Weinberg, Richard R. Furman, Tait D. Shanafelt, James R. Cerhan, Sameer A. Parikh, Esteban Braggio, Susan L. Slager
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2118–2129.
https://doi.org/10.1182/bloodadvances.2023012242
Published: 2024
Includes: Supplemental data
Journal Articles

Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL

Rosalie Griffin, Julia E. Wiedmeier-Nutor, Sameer A. Parikh, Chantal E. McCabe, Daniel R. O'Brien, Nicholas J. Boddicker, Geffen Kleinstern, Kari G. Rabe, Laura Bruins, Sochilt Brown, Cecilia Bonolo de Campos, Wei Ding, Jose F. Leis, Paul J. Hampel, Timothy G. Call, Daniel L. Van Dyke, Neil E. Kay, James R. Cerhan, Huihuang Yan, Susan L. Slager, Esteban Braggio
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3169–3179.
https://doi.org/10.1182/bloodadvances.2022009040
Published: 2023
Includes: Supplemental data